Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Comment by reconsideron Jan 22, 2025 9:59am
138 Views
Post# 36414969

RE:Q1 it is, imho

RE:Q1 it is, imhoBeyond BTD what we need is the legitimization of a solid partnership.
BTD might be the basis for this to happen but even if BTD is not granted, Theralase MUST have a plan B for a partnership. Period. There is no way this company can start other trials at the pace and amount money is raised.

I'm yet to see Dr. Lbiati giving Theralase a meaningful (if any) shout-out in her Linkedin / X accounts.

2025 is a year to start delivering. It is discouraging to see how we fail to stick to timelines in mere weeks.
In November there was this email by MP expecting BTD resolution by Q1 and Canadian grant by year end.
A month later, unfulfiled. 

Nothing else to do but wait until the spring.
<< Previous
Bullboard Posts
Next >>